Por: The Hill Health March 09, 2023
COVID-19 patients who took the diabetes drug metformin for two weeks after a diagnosis were less likely to develop long COVID-19 symptoms, according to . The trial enrolled about a thousand participants who were symptomatic with a COVID-19 infection for less than a week. Participants were randomly selected to receive a placebo or one of three drugs: metformin, ivermectin or fluvoxamine. Metformin may help prevent long COVID-19 by reducing... + full article
Ars Technica USA Science February 16, 2023
Navigate Filter by topic Settings Front page layout Site theme - Feb 16, 2023 4:57 pm UTC / A woman with diabetes pricks her finger to take a blood sample to measure the glycemia in Paris on March 24, 2020. Share this story A person's odds of getting a new diabetes... + más
Type 1 Diabetes: U.K. To Launch Childhood Screening Program | Forbes
Do Statins Increase the Risk of Diabetes? | The New York Times
The New York Times USA Business January 27, 2023
For individuals suffering from a deadly disease, clinical trials for drugs offer lifesaving hope. But for all the rapid advances in science and medicine, some of the building blocks of clinical trials — the back-end technology, data aggregation and patient recruitment —... + más
Fintech Company Greenphire Wants To Make Clinical Trials More Representative Of Every Person, From All Backgrounds And Abilities | Forbes
Shocked By Disparities In Access To Clinical Trials, This Medical Student Decided To Change Things | Forbes
Orlando Sentinel USA Nation January 20, 2023
Central Florida residents now have access to the first-ever treatment to delay Type 1 diabetes. In November, the U.S. Food and Drug Administration approved Provention Bio and Sanofi’s monoclonal antibody teplizumab — marketed as Tzield, for prediabetic adults and children... + más
FDA approves 1st drug to delay onset of Type 1 diabetes | ABC News
FDA Oks Provention Bio's Tzield To Delay Onset Of Type 1 Diabetes | RTTNews
ABC News USA Health November 18, 2022
For the first time, the U.S. Food and Drug Administration on Thursday approved a treatment that can delay the onset of .Teplizumab, a monoclonal antibody that will be marketed under the brand name Tzield from pharmaceutical companies ProventionBio and Sanofi, is administered... + más
FDA approves 1st drug to delay the onset of Type 1 diabetes | NBC News
Forbes USA Tech November 15, 2022
A young girl with diabetes injects herself with insulin. getty Twenty thousand U.K. children will be screened for type one diabetes in a landmark study that could lead to a national scheme. The (EarLy Surveillance for Autoimmune diabetes) program will use blood tests to identify... + más
What to Know About Bariatric Surgery for Type 2 Diabetes | Time
Time USA Health November 04, 2022
The term bariatric is derived from the Greek words for “weight” and “to treat.” Originally, as its name denotes, this form of surgery was aimed at helping people manage obesity. But as medical science’s understanding of bariatric surgery improved, experts recognized... + más
Why people with diabetes are more likely to suffer dreaded ‘trigger finger’ | New York Post
Forbes USA Business October 03, 2022
Greenphire is working to make clinical trials more equitable and accessible to everyone. Google Images Clinical trial company Greenphire as “the leading provider of global financial lifecycle management solutions for clinical trials, delivering the most complete data and... + más
Market turbulence, inflation, geopolitical uncertainty prompt dip in fintech investment: KPMG | Fox Business
Risk concerns, comorbidities and more keep many from clinical trials: Alzheimers Q&A | The Advocate
About iurex | Privacy Policy | Disclaimer |